Liver Status Improves Targeted Therapy Selection in Mets CRC Liver Status Improves Targeted Therapy Selection in Mets CRC
Adding liver metastases status to tumor sidedness may enhance first-line targeted treatment selection in certain patients with metastatic colorectal cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Hematology | Liver | Urology & Nephrology